Loading
Latest filing published 21 Apr 2026 for Oryx International Growth Fund Limited, €18k. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher Mills appears in our data through filings on Oryx International Growth Fund Limited shares, published by RNS (LSE). We count 3 filings; the first trade dates from 7 April 2026 and the latest from 20 April 2026.
Every open-market trade on record is a purchase: 3 purchases worth €115k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €23k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 3 purchases show a median change of +1.6%, with the price up in 67% of them. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 21 April 2026 with an open-market purchase (€18k) in Oryx International Growth Fund Limited. Between a trade and the moment it shows up on RNS (LSE), the median delay is 4 days. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations